Series A startup

Who invested in Akrivia Health

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.9Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $5.9MJun 2021
Investors
1
See who backed them

The rounds

  1. Jun 2021
    Series A$5.9M

    Source recorded

Founders and team

From Akrivia Health's own website: 2 founders, 11 on the team.

David NewtonCo-Founder & Chief Executive Officer
Mike DenisCo-Founder & Non Executive Director
  • Amy JaggersChief of Staff
  • Charlotte GoodwinChief Financial Officer
  • Philip McguireChief Medical Officer
  • Byron TibbittsHead of Programmes
  • Luke FernandoHead of Engineering
  • Molly FarrowHead of Legal
  • Dr Benjamin FellDirector of Research
  • Faces Behind AkriviaBoard of Directors
  • Hailey LefkofskyBoard Member
  • Sanjeev PooniGlobal Commercial Director
  • Steve SilveyBoard Member (University of Oxford Board Member)

AdvisersSimon Lovestone

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Akrivia Health

Who invested in Akrivia Health?

Akrivia Health's investors include Future Planet Capital.

How much has Akrivia Health raised?

Akrivia Health has raised $5.9M across 1 round since 2021.

When did Akrivia Health last raise?

Akrivia Health's most recent round was a Series A of $5.9M in Jun 2021.

What was Akrivia Health's biggest round?

Its most recent round, $5.9M in Jun 2021, is also its largest on record.

Who backed Akrivia Health first?

Akrivia Health's first round on record, in Jun 2021, was backed by Future Planet Capital.

What stage is Akrivia Health at?

Akrivia Health's latest named round is a Series A, in Jun 2021.

Companies like Akrivia Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.